Delivery Order SPE2DB24D1007-SPE2DB25FCCLK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This order, valued at $13,846.97 with a firm fixed price structure, represents a non-competitive, non-set-aside procurement issued under a delivery order contract type and is scheduled for completion by August 18, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $13,846.97 and has a firm fixed price structure with an ultimate completion date of September 18, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. This is a firm fixed price delivery order with completion scheduled for October 10, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on August 22, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 for Vyndamax 61 mg capsule unit dose 30-count packages on August 25, 2025. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency (DLA) awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract, issued under firm fixed pricing with no set-aside designation, is scheduled for completion by September 24, 2025, and represents a competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Vyndamax 61 mg capsule unit dose 30s, a pharmaceutical product for federal medical procurement needs. This competitively awarded, firm fixed price delivery order is not set-aside and is scheduled for completion by October 6, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $27,693.94 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by May 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its Corporate Office location. This delivery order operates under...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCLKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This competitive, non-set-aside contract employs firm fixed pricing and is scheduled for completion by August 1, 2025. The award was issued on July 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's pharmaceutical supply relationship with the federal government for military and healthcare system needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its established capability to meet competitive procurement requirements for critical pharmaceutical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 7/11/25 |